Taken together, these data reinforce our conclusion that the effect of delphinidin on melanoma-induced tumor growth in both in vivo and in vitro is mainly due to its action on endothelial cells and probably VEGFR2 signalling participates to its action. The gene discussed is KDR; the disease is melanoma.